Fyarro Alternatives Compared
| Fyarro (sirolimus protein-bound) | Sirolimus protein-bound |
|
|---|
| Fyarro (sirolimus protein-bound) | Sirolimus protein-bound |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Malignant Perivascular Epithelioid Cell Tumor. Fyarro may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Malignant Perivascular Epithelioid Cell Tumor. Sirolimus protein-bound may also be used for purposes not listed in this medication guide. |
||||||||
| More about Fyarro (sirolimus protein-bound) | More about Sirolimus protein-bound | ||||||||
| Ratings & Reviews | |||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Fyarro side effects |
View all Sirolimus protein-bound side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Fyarro prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
|
N/A |
Fyarro | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
59 hours |
59 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 408 drugs are known to interact with Fyarro:
|
A total of 408 drugs are known to interact with Sirolimus protein-bound:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Afinitor Disperz
Afinitor Disperz is used for subependymal giant cell astrocytoma, tuberous sclerosis complex
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Hyftor
Hyftor (sirolimus topical gel) is used for facial angiofibroma associated with tuberous sclerosis ...
Rapamune
Rapamune (sirolimus) is used to prevent rejection in people who have received a kidney transplant ...
Torisel
Torisel is used to treat cancer of the kidneys, also called renal cell carcinoma. Learn about side ...
Zortress
Zortress (everolimus) is used to prevent organ rejection in adult kidney transplant recipients ...
Sirolimus topical
Sirolimus topical is used for angiofibroma, tuberous sclerosis complex
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.